Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 40, 2010 - Issue 5
329
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Stereoselective Synthesis of (+)-Nephrosteranic Acid by Ring-Closing Metathesis and Its Biological Evaluation

, , &
Pages 686-696 | Received 17 Jan 2009, Published online: 04 Feb 2010
 

Abstract

A simple and efficient approach to (+)-nephrosteranic acid from dodecanol as a starting material is described, employing Sharpless asymmetric epoxidation, ring-closing metathesis, and Gilman addition of a vinyl group as key steps. These key reactions allow fast access to trisubstituted γ-butyrolactone. The molecule synthesized exhibits potent antifungal, antibacterial, and cytotoxic activities against all the tested strains.

ACKNOWLEDGMENTS

We thank the director of the Indian Institute of Chemical Technology, project director of NIPER, and head of the Organic Chemistry Division II for their encouraging support. P.A.K. thanks the Council of Scientific and Industrial Research for fellowship.

Notes

a MIC (minimum inhibitory concentration in μg/mL) was determined as 90% inhibition of growth with respect to positive growth control. Negative control: DMSO, no inhibition.

b SA, Staphylococcus aureus; SE, Staphylococcus epidermis; EC, Escherichia coli; PA, Psudomonas aeruginosa.

c SS, Saccharomyces serviseae; CA, Candida albicans; AN, Aspergillus niger; RA, Rhizopus orizae.

a IC50: Inhibitory concentration.

b THP-1: Human acute monocytic leukemia cell line.

c Human leukemic monocyte lymphoma cell line.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.